P9H-14934-39410
2 vaccinations
1 coded response
9 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 620 / IL
- Registered
- 2021-01-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-05
Dose 1 — Pfizer-BioNTech
-
2021-01-26
Dose 2 — Pfizer-BioNTech
-
2021-01-28
Registered in v-safe
-
2021-01-28
Survey response — days 1–6 daily, dose 2MedDRA: Maternal exposure during pregnancy, Postpartum disorder, Postpartum state — Feeling: GoodFree text: Also I didnt know where to put it but I was 37 weeks pregnant when I had my first dose and two weeks post partum with the secondMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-29
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-10
- 2021-02-16
- 2021-07-29
- 2022-01-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-05 | Pfizer-BioNTech | |
| 2 | 2021-01-26 | Pfizer-BioNTech |
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Also I didnt know where to put it but I was 37 weeks pregnant when I had my first dose and two weeks post partum with the second
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Maternal exposure during pregnancy | ○ | ✓ | ○ |
| SRO | Postpartum disorder | ○ | ✓ | ○ |
| SRO | Postpartum state | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release